Effects of intranasally applied dopamine on behavioral asymmetries in rats with unilateral 6-hydroxydopamine lesions of the nigro-striatal tract

Neuroscience

Volumn 162, Issue 1, 2009, Pages 174-183

  Pum, M E ^a   Schable S ^a   Harooni, H E ^c   Topic, B ^a   De Souza Silva, M A ^a   Li, J S ^b   Huston, J P ^a   Mattern, C ^d  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

^c UNIVERSITY OF TEHRAN   (Iran)

^d M et P Pharma AG   (Switzerland)

Author keywords

6 hydroxydopamine; behavioural asymmetry; forepaw use; intranasal dopamine; turning behaviour

Indexed keywords

AMPHETAMINE; APOMORPHINE; DOPAMINE; OXIDOPAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; BRAIN DAMAGE; CELL ACTIVITY; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; MALE; NERVE POTENTIAL; NERVE STIMULATION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PERIKARYON; PRIORITY JOURNAL; RAT;

ADMINISTRATION, INTRANASAL; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FORELIMB; MALE; MOTOR ACTIVITY; NOREPINEPHRINE; NUCLEUS ACCUMBENS; OXIDOPAMINE; PREFRONTAL CORTEX; RATS; RATS, WISTAR; SEROTONIN; SUBSTANTIA NIGRA;

EID: 67349131550     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.04.051     Document Type: Article

References (19)

1. Barragan E.I., and Ferreyra-Moyano H. Ventrostriopallidal functional interconnections with cortical and quasi-cortical regions. Brain Res Bull 37 (1995) 329-336
2. Buddenberg T.E., Topic B., Mahlberg E.D., de Souza Silva M.A., Huston J.P., and Mattern C. Behavioral actions of intranasal application of dopamine: effects on forced swimming, elevated plus-maze and open field parameters. Neuropsychobiology 57 (2008) 70-79
3. Cador M., Bjijou Y., and Stinus L. Evidence of a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine. Neuroscience 65 (1995) 385-395
4. Cenci M.A., Whishaw I.Q., and Schallert T. Animal models of neurological deficits: how relevant is the rat?. Nat Rev Neurosci 3 (2002) 574-579
5. Dahlin M., Jansson B., and Björk E. Levels of dopamine in blood and brain following nasal administration to rats. Eur J Pharm Sci 14 (2001) 75-80
6. De Souza Silva M.A., Mattern C., Häcker R., Nogureia P.J., Huston J.P., and Schwarting R.K. Intranasal administration of the dopaminergic agonists L-DOPA, amphetamine, and cocaine increases dopamine activity in the neostriatum: a microdialysis study in the rat. J Neurochem 68 (1997) 233-239
7. De Souza Silva M.A., Topic B., Huston J.P., and Mattern C. Intranasal dopamine application increases dopaminergic activity in the neostriatum and nucleus accumbens and enhances motor activity in the open field. Synapse 62 (2008) 176-184
8. Fornaguera J., Huston J.P., Carey R.J., and Schwarting R.K.W. Stimulation of D1- or D2-receptors in drug-naïve rats with different degrees of unilateral nigro-striatal dopamine lesions. Psychopharmacology 119 (1995) 145-154
9. Illum L. Transport of drugs from the nasal cavity to the central nervous system. Eur J Pharm Sci 11 (2000) 1-18
10. Lundblad M., Andersson M., Winkler C., Kirik D., Wierup N., and Cenci M.A. Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease. Eur J Neurosci 15 (2002) 120-132
11. Masini C.V., Holmes P.V., Freeman K.G., Maki A.C., and Edwards G.L. Dopamine overflow is increased in olfactory bulbectomized rats: an in vivo microdialysis study. Physiol Behav 81 (2004) 111-119
12. Maurice N., Deniau J.M., Menetrey A., Glowinski J., and Thierry A.M. Position of the ventral pallidum in the rat prefrontal cortex-basal ganglia circuit. Neuroscience 80 (1997) 523-534
13. Prediger R.D.S., Batista L.C., Medeiros R., Pandolfo P., Florio J.C., and Takahashi R.N. The risk is in the air: intranasal administration of MPTP to rats reproducing clinical features of Parkinson's disease. Exp Neurol 202 (2006) 391-403
14. Ruocco LA, de Souza Silva MA, Topic B, Mattern C, Huston JP, Sadile AG (in press) Intranasal application of dopamine reduces activity and improves attention in Naples high excitability rats that feature the mesocortical variant of ADHD. Eur Neuropsychopharmacol; DOI: 10.1016/j.euroneuro.2009.02.005.
15. Schallert T., Fleming S.M., Leasure J.L., Tillerson J.L., and Bland S.T. CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, Parkinsonism and spinal cord injury. Neuropharmacology 39 (2000) 777-787
16. Schapira A.H.V. Neurobiology and treatment of Parkinson's disease. Trends Pharmacol Sci 30 (2008) 41-47
17. Schwarting R.K.W., Bonatz A.E., Carey R.J., and Huston J.P. Relationships between indices of behavioral asymmetries and neurochemical changes following mesencephalic 6-hydroxydopamine injections. Brain Res 554 (1991) 46-55
18. Schwarting R.K.W., and Huston J.P. The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments. Prog Neurobiol 50 (1996) 275-331
19. Schwarting R.K., Goldenberg R., Steiner H., Fornaguera J., and Huston J.P. A video image analyzing system for open-field behavior in the rat focusing on behavioral asymmetries. J Neurosci Methods 49 (1993) 199-210